False-positive mammogram results discourage some women from future screenings
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
Study Showed Over 10% of Medicare Beneficiaries Have Diagnoses Indicating Dementia
On Sept. 3, 2024, researchers at NORC at the University of Chicago and George Washington University’s Milken Institute…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
CIRM Awarded $67.5 Million to Address Neuropsychiatric Diseases
On Aug. 30, 2024, the California Institute for Regenerative Medicine (CIRM) approved $67.5 million to support five projects…
Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Biotechnology | Disease | Therapeutics | Vaccine | WHO
Global strategic preparedness and response plan launched by WHO to contain mpox outbreak
On Aug. 26, 2024, the World Health Organization (WHO) launched a global Strategic Preparedness and Response Plan to…
first drug approved for early Alzheimer’s disease in the UK
On Aug. 22, 2024, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it had licensed the immunotherapy…
CPRIT awarded more than $60 million to boost fight against cancer
On Aug. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Multi-year, 1143-patient genetic study identified unique types of multiple myeloma
On Aug. 19, 2024, an international team of scientists led by researchers from the Translational Genomics Research Institute (TGen) announced…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine
CDC reported COVID-19 at highest level in two years
On Aug. 16, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 infections are…
ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely
ON Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) reported that it is highly…
Western university announced newly discovered protein stops dNA damage
On Aug. 15, 2024, researcher from from Western University announced they had discovered a protein that has the…
international team of scientists announced mapping complete genetic makeup of Lyme disease-causing bacteria
On Aug. 14, 2024, an international team of scientists announced they had sequenced the complete genomes of the…
International Study Detected Consciousness in Unresponsive Patients
On Aug. 14, 2024, a study co-led by Mass General Brigham found that one in four patients with…
City birds found to be carriers of antimicrobial resistant bacteria
on Aug. 14, 2024, research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
Artificial Intelligence | Biotechnology | Diagnostics | Medicine | Non-Profit Research | Therapeutics
HHMI Invested $500 Million in AI-Driven Life Sciences Research
On Aug. 12, 2024, The Howard Hughes Medical Institute (HHMI) announced AI@HHMI, a $500 million investment over the…
Largest Protein Yet Discovered Builds Algal Toxins
On Aug. 8, 2024, scientists at UC San Diego’s Scripps Institution of Oceanography announced they had discovered the…
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Received U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Therapeutics
FDA Approved ‘First Gene Therapy’ to Treat Adults with Metastatic Synovial Sarcoma
On Aug. 2, 2024, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra (afamitresgene autoleucel), a gene therapy…
the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
Maryland Department of Health issued consumer advisory for Boar’s Head liverwurst and other deli meat products due to possible Listeria contamination
On Jul. 26, 2024, the Maryland Department of Health advised consumers not to eat certain deli meats produced…
Boar’s Head Recalls Ready-To-Eat Liverwurst And Other Deli Meat Products Due to Possible Listeria Contamination
On Jul. 26. 2024, Boar’s Head, a Jarratt, Va., establishment, announced it was recalling all liverwurst product produced…
European Commission Approved Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
CIRM approved $8 million award for plasma cell disorder therapy, $27 million to boost collaboration among California researchers
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…